PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5M 5M 7.5M Q1 '14: 213 Q2 '14: 213 Q3 '14: 213 Q4 '14: 213 Q1 '15: 0 Q2 '15: 0 Q3 '15: 0 Q4 '15: 213 Q1 '16: 0 Q2 '16: 0 Q3 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 16K Q2 '19: 60.2K Q3 '19: 60.2K Q4 '19: 129.9K Q1 '20: 836K Q2 '20: 6.2M Q3 '20: 1.3M Q4 '20: 712.1K Q1 '21: 512.1K Q2 '21: 313.5K Q3 '21: 588K Q4 '21: 646K Q1 '22: 466.5K Q2 '22: 469.5K Q3 '22: 366.2K Q4 '22: 324.8K Q1 '23: 677.5K Q2 '23: 399.1K Q3 '23: 347.9K Q4 '23: 960.5K Q1 '24: 1.1M Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q3 '22 Q1 '24

Gross Profit Quarterly

-3M -1.5M 0 1.5M 3M 4.5M Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 3.4K Q2 '19: -40.3K Q3 '19: -40.3K Q4 '19: -1.7M Q1 '20: -564.3K Q2 '20: 3.2M Q3 '20: -1.6M Q4 '20: 938.4K Q1 '21: 182.3K Q2 '21: 64.8K Q3 '21: 283K Q4 '21: 10.4K Q1 '22: 100.4K Q2 '22: 138K Q3 '22: 47.3K Q4 '22: 110.8K Q1 '23: 225.6K Q2 '23: 202.8K Q3 '23: 146.6K Q4 '23: 546.9K Q1 '24: 666.2K Q1 '18 Q1 '19 Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '14: -87.8K Q2 '14: -17.1K Q3 '14: -74.9K Q4 '14: -240.4K Q1 '15: -64K Q2 '15: -102.4K Q3 '15: -102.4K Q4 '15: -69.7K Q1 '16: -233.4K Q2 '16: -260.9K Q3 '16: -359.8K Q4 '16: -747.4K Q1 '17: -601K Q2 '17: -506.3K Q3 '17: -490.2K Q4 '17: -1.5M Q1 '18: -1.4M Q2 '18: -296.2K Q3 '18: -425.9K Q4 '18: -584.7K Q1 '19: -2.6M Q2 '19: -2M Q3 '19: -2M Q4 '19: -5M Q1 '20: -2.6M Q2 '20: 802.6K Q3 '20: -3.3M Q4 '20: -1.7M Q1 '21: -1.1M Q2 '21: -1.4M Q3 '21: -1.3M Q4 '21: -2.1M Q1 '22: -1.6M Q2 '22: -1.2M Q3 '22: -1.4M Q4 '22: -1.4M Q1 '23: -1.3M Q2 '23: -1.1M Q3 '23: -1.4M Q4 '23: -1.8M Q1 '24: -1.1M Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q3 '22 Q1 '24

Net Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '14: 26.4K Q2 '14: -7.7K Q3 '14: -74.9K Q4 '14: -240.4K Q1 '15: -63.8K Q2 '15: -112.6K Q3 '15: -112.6K Q4 '15: -28.4K Q1 '16: -234.8K Q2 '16: -260.9K Q3 '16: -359.8K Q4 '16: -747.4K Q1 '17: -601K Q2 '17: -506.3K Q3 '17: -717.8K Q4 '17: -2M Q1 '18: -1.1M Q2 '18: -559.7K Q3 '18: -1.6M Q4 '18: -1.1M Q1 '19: -1.4M Q2 '19: -2M Q3 '19: -2M Q4 '19: -5.5M Q1 '20: -2.8M Q2 '20: 655.2K Q3 '20: -3.8M Q4 '20: -87.5K Q1 '21: 370.6K Q2 '21: 27.2K Q3 '21: -3.1M Q4 '21: -2.1M Q1 '22: -2.8M Q2 '22: -2M Q3 '22: -2.7M Q4 '22: -1.7M Q1 '23: -1.8M Q2 '23: -1.9M Q3 '23: -2.2M Q4 '23: -2.2M Q1 '24: -1.4M Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q3 '22 Q1 '24

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 12.6K Q2 '19: 0 Q3 '19: 100.4K Q4 '19: 1.9M Q1 '20: 1M Q2 '20: 3M Q3 '20: 2.9M Q4 '20: 734.3K Q1 '21: 329.8K Q2 '21: 248.6K Q3 '21: 305K Q4 '21: 635.5K Q1 '22: 366.1K Q2 '22: 331.5K Q3 '22: 318.9K Q4 '22: 214K Q1 '23: 451.9K Q2 '23: 196.3K Q3 '23: 201.2K Q4 '23: 413.6K Q1 '24: 390.3K Q1 '18 Q1 '19 Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '14: -15.1K Q4 '14: -289.5K Q1 '15: -81.2K Q2 '15: -407.8K Q3 '15: -81.9K Q4 '15: -69.1K Q1 '16: -166.5K Q2 '16: -188.3K Q3 '16: -129.3K Q4 '16: -406.8K Q1 '17: -783.4K Q2 '17: -326.8K Q3 '17: -93.9K Q4 '17: -30.8K Q1 '18: -295.3K Q2 '18: -38.7K Q3 '18: -73.9K Q4 '18: -57.8K Q1 '19: -1.8M Q2 '19: -1.7M Q3 '19: -1.5M Q4 '19: -718.6K Q1 '20: -164.3K Q2 '20: -5.9M Q3 '20: -600.3K Q4 '20: -1M Q1 '21: -795.2K Q2 '21: -1.1M Q3 '21: -752.5K Q4 '21: -1.2M Q1 '22: -436K Q2 '22: -729.5K Q3 '22: -711.1K Q4 '22: -523K Q1 '23: -313.9K Q2 '23: -483.3K Q3 '23: -728.9K Q4 '23: 1.6K Q1 '24: -357.1K Q2 '15 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '14: -15.1K Q4 '14: -291K Q1 '15: -82.7K Q2 '15: -409.3K Q3 '15: -81.9K Q4 '15: -69.1K Q1 '16: -166.5K Q2 '16: -189.6K Q3 '16: -129.3K Q4 '16: -406.8K Q1 '18: -295.3K Q2 '18: -38.7K Q3 '18: -73.9K Q4 '18: -57.8K Q1 '19: -1.9M Q2 '19: -2M Q3 '19: -1.7M Q1 '20: -164.3K Q2 '20: -5.9M Q3 '20: -3.9M Q4 '20: -1.1M Q1 '21: -882K Q2 '21: -1.2M Q3 '21: -766.3K Q4 '21: -1.2M Q1 '22: -445.8K Q2 '22: -737.3K Q3 '22: -838.4K Q4 '22: -621.8K Q1 '23: -329.1K Q2 '23: -492.7K Q1 '24: -362.1K Q2 '15 Q2 '16 Q2 '18 Q2 '19 Q3 '20 Q3 '21 Q3 '22 Q1 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8M 16M 24M Q2 '20: 16.9M Q3 '20: 16.9M Q1 '21: 21.9M Q2 '21: 16.9M Q3 '21: 21.4M Q1 '22: 14.8M Q2 '22: 15M Q3 '22: 14.9M Q1 '23: 15M Q2 '23: 17.6M Q3 '23: 16.6M Q1 '24: 16.5M Q3 '20 Q2 '21 Q1 '22 Q3 '22 Q2 '23 Q1 '24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q4 '14: -0.02 Q1 '15: -0.16 Q2 '15: -0.38 Q3 '15: -0.38 Q4 '15: -0.42 Q1 '16: -0.83 Q2 '16: -0.64 Q3 '16: -0.64 Q4 '17: -0.92 Q1 '18: -1.14 Q2 '18: -1.24 Q3 '18: -1.55 Q4 '18: -0.91 Q1 '19: -0.74 Q2 '19: -0.67 Q3 '19: -0.39 Q4 '19: -0.32 Q1 '20: -0.31 Q2 '20: -0.22 Q3 '20: -0.39 Q4 '20: -0.39 Q1 '21: -0.31 Q2 '21: -0.35 Q3 '21: -0.27 Q4 '21: -0.24 Q1 '22: -0.45 Q2 '22: -0.58 Q3 '22: -0.62 Q4 '22: -0.62 Q1 '23: -0.55 Q2 '23: -0.53 Q3 '23: -0.48 Q4 '23: -0.49 Q1 '24: -0.46 Q3 '15 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.